| Name
|
Fibrinogen Binding Inhibitor Peptide
|
| Other Name
|
Fibrinogen Binding Inhibitor
|
| Sequence (Single letter abbreviations)
|
HHLGGAKQAGDV
|
| Sequence（Three letter abbreviations）
|
{HIS}{HIS}{LEU}{GLY}{GLY}{ALA}{LYS}{GLN}{ALA}{GLY}{ASP}{VAL}
|
| Basic description
|
Fibrinogen Binding Inhibitor Peptide, a synthetic dodecapeptide, represents the specific platelet receptor recognition site of the human fibrinogen g-chain (residues 400-411). It is also a potent inhibitor of the binding of fibrinogen, fibronectin, and von Willebrand factor to thrombin- or ADP-stimulated platelets. Fibrinogen Binding Inhibitor Peptide has been used in studying phosphorylation processes associated with platelet activation.
|
| Solubility
|
Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents.
|
| The molecular weight
|
1189.300
|
| Chemical formula
|
C50H80N18O16
|
| The purity
|
> 95%
|
| Storage conditions
|
Before using, store the peptide in the DRY form at 0-5°C. For and repeatable results, rehydrate the peptide immediately before using. Do not re-freeze any unused portions.
|
| Annotation
|
In activated platelets, single γ 400-411 sequence is no longer required for initiation of adhesion but becomes sufficient for firm adhesion. In contrast to the binding of whole fibrinogen, binding of fragment 400-411 does not lead to tyrosine phosphorylation for platelet proteins.
|
| Documents
|
|
| Figures
|
|
| Reference
|
|
Fibrinogen Binding Inhibitor Peptide
